1. Beer HF, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, et al.In vitro andin vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors.J Nucl Med 1990; 31: 1007–1014.
2. Holl K, Deisenhammer E, Dauth J, Carmann H, Schubiger PA. Imaging benzodiazepine receptors in the human brain by single photon emission computed tomography (SPECT).Nucl Med Biol 1989; 16: 759–763.
3. Uchiyama M, Sue H, Fukumitsu N, Mori Y, Kawakami K. Assessment of cerebral benzodiazepin receptor distribution in anxiety disorders by123I-iomazenil-SPECT: comparison to cerebral perfusion scintigraphy by123I-IMP.NIPPON ACTA RADIOLOGICA 1997; 57: 41–46.
4. Nakabeppu Y, Nakajo M, Naruo T, Obo Y, Nozoe S, Takigawa M, et al. I-123 iomazenil SPECT in patients with mental disorders.Ann Nucl Med 1997; 11: 339–344.
5. Tokunaga M, Ida I, Higuchi T, Mikuni M. Alterations of benzodiazepine receptor binding potential in anxiety and somatoform disorders measured by123I-iomazenil SPECT.Radiation Medicine 1997; 15: 163–169.